JohnCheretis

Associate

Washington + 1.202.879.3424

John Cheretis counsels and represents clients in international trade and government contracting matters. He has advised importers in various types of U.S. customs matters, such as submitting ruling requests and prior disclosures and has represented clients before the United States Trade Representative regarding additional duties imposed under Section 301 of the Trade Act of 1974.

John also has represented clients seeking to engage in foreign direct investment and other transactions that implicate international trade concerns, such as review by the Committee on Foreign Investment in the United States (CFIUS). He has assisted clients in navigating and understanding economic sanctions and export control issues, including sanctions regimes administered by the Office of Foreign Assets Control (OFAC), the International Traffic in Arms Regulations (ITAR), and the Export Administration Regulations (EAR).

John also maintains an active pro bono practice. He has represented U.S. veterans in obtaining disability benefits as well as individuals seeking asylum and other forms of immigration relief.

Experience

  • STERIS to acquire Cantel Medical for $3.6 billionJones Day is advising STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers for $3.6 billion.
  • DataBank acquires zColoJones Day advised DataBank, a leading provider of enterprise-class colocation, connectivity, and managed services, in connection with the acquisition and financing of zColo, including certain U.S. and European data center assets, from Zayo Group Holdings, Inc.
  • STERIS acquires Key Surgical for approximately $850 millionJones Day advised STERIS plc (NYSE: STE) in the $850 million acquisition of Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products, and a portfolio company of Water Street Healthcare Partners, LLC.
  • PureCycle Technologies to combine with Roth CH Acquisition I Co.Jones Day is advising PureCycle Technologies LLC ("PureCycle") in its business combination with Roth CH Acquisition I Co. ("Roth SPAC"), a publicly-traded special purpose acquisition corporation backed by Roth Capital Partners and Craig-Hallum Capital Group, and Roth CH Acquisition I Co. Parent Corp., a wholly owned subsidiary of Roth CH ("Holdings"), among others.
  • UPMC prevails in trial before Commonwealth Court of PennsylvaniaJones Day won a bench trial on behalf of the University of Pittsburgh Medical Center ("UPMC"), one of the nation's preeminent integrated healthcare systems.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.